| ADPT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ADPT shares outstanding history going back to 6/27/2019:
Also see: ADPT Market Cap History ADPT YTD Return |
ADPT Shares Outstanding History — Adaptive Biotechnologies Share Count Over Time
As of 4/30/2026 Adaptive Biotechnologies has 160.04 million ADPT shares outstanding. Investors often track the ADPT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ADPT share count trends over time, with 29 historical shares outstanding datapoints presented, dating back to 6/27/2019.
| ADPT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADPT Historical Shares Outstanding: +4.49% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADPT Stock Price Chart |
| About Adaptive Biotechnologies Corp |
| Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. Co. is focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its proprietary technologies to read the diverse genetic code of a patient's immune system and understand precisely how the immune system detects and treats disease in that patient. It has business around two main areas: clinical assessment of minimal residual disease (MRD) in lymphoid malignancies and immune medicine (IM)-driven drug discovery and development. We show 29 historical shares outstanding datapoints in our coverage of ADPT's shares outstanding history. Understanding the changing numbers of ADPT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADPT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADPT by allowing them to research ADPT shares outstanding history as well as any other stock in our coverage universe. |
| ADPT Current Stock Quote |
Quotes delayed 20 minutes  Free ADPT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ADPT Share Performance |
| Shares Outstanding Peers |
| Adaptive Biotechnologies (ADPT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ADRO Shares Outstanding History ADTX Shares Outstanding History ADUS Shares Outstanding History ADVM Shares Outstanding History ADXS Shares Outstanding History ADYX Shares Outstanding History AEMD Shares Outstanding History AERI Shares Outstanding History AEZS Shares Outstanding History AFIB Shares Outstanding History More Healthcare companies » |
ADPT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
